NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Borrowings History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Borrowings | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr | ₹314 Cr |
What is the latest Short Term Borrowings ratio of NATCO PHARMA ?
Year | Short Term Borrowings |
---|---|
Mar2024 | ₹363 Cr |
Mar2023 | ₹165 Cr |
Mar2022 | ₹404 Cr |
Mar2021 | ₹266 Cr |
Mar2020 | ₹314 Cr |
How is Short Term Borrowings of NATCO PHARMA Trending?
Years | Short Term Borrowings | % Change | |
---|---|---|---|
Mar2024 | ₹363 Cr | 120.12 | |
Mar2023 | ₹165 Cr | -59.16 | |
Mar2022 | ₹404 Cr | 51.99 | |
Mar2021 | ₹266 Cr | -15.40 | |
Mar2020 | ₹314 Cr | - |
Compare Short Term Borrowings of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹21,044.3 Cr | -9.8% | -15.3% | 32% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -9.8% |
-15.3% |
32% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses